Anthony Bradshaw Gold prices are surging to record levels amid a complex global economic backdrop, including potential U.S. Federal Reserve rate cuts and ongoing geopolitical risks. With its low correlation to equities and ability to help mitigate recessionary and inflationary pressures, gold’s attractiveness is underscored by robust demand from emerging market central banks – allowing…
Bloomberg/Bloomberg via Getty Images By Daniel Scher, Portfolio Manager, Research Analyst, Franklin Equity Group | Blair Schmicker, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group In his recent article “Quick Thoughts: Five surprises for 2024,” Head of Franklin Institute, Stephen Dover, opines that 2024 could mark the return of secular stagnation, where economic growth slows,…
Bloomberg/Bloomberg via Getty Images Tech companies that are decelerating and have been tossed into the penalty bucket have one quick means of escape: interest from a private equity buyer. And potential rumors are the main ingredient behind DocuSign’s (NASDAQ:DOCU) recent recovery rally, with the stock shooting up more than 40% since the start of November….
remotevfx/iStock via Getty Images Invesco Solar ETF (NYSEARCA:TAN) is one I’ve followed for many years, and I’ve come to regard it as one of my go-to ETFs in the alternative energy sector. It gets a Hold rating from me, but that’s akin to saying that when the sun is out, it is warm. Ask someone…
Lemon_tm By Ewa Manthey, Commodities Strategist Rising yields and dollar strength weigh on gold Refinitiv Eikon, ING Research A still hawkish Federal Reserve, a strong dollar, and higher yields are weighing on gold. US 10-year Treasury yields hit their highest levels since 2007 this week, whilst the USD index is at its strongest level since…
Ozgu Arslan Seres Therapeutics (NASDAQ:MCRB) is a small ($615 million market cap) commercial-stage company developing microbiome therapeutics (Figure 1) for serious diseases. On June 5, Seres and 50-50 partner Nestlé (OTCPK:NSRGY) launched VOWST (live fecal microbiota spores), the first orally administered microbiota-based therapeutic to prevent recurrence of Clostridioides (Clostridium) difficile infection (‘CDI’) in adults following…